D Shao1, S M Rangwala, S T Bailey
1Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Peroxisome proliferator-activated receptor gamma (PPAR-gamma) ligand binding is regulated by its amino-terminal domain. This interaction impacts adipocyte differentiation and insulin sensitivity, influencing therapeutic ligand development.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: